Login

Company Executives

Officer Age In this role Source
Weidong Yin Also a director
Director, Chief Executive Officer
62 Not stated
Nan Wang
Chief Financial Officer, Vice President
59 Since 2013
13 years
Qiang Gao
Chief Operating Officer, Vice President
49 Since 2020
6 years
Guang (Helen) Yang
Chief Business Officer
46 Since 2021
5 years
Jing Li
Vice President, Quality and Production
52 Since 2016
10 years

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the 20-F annual report

Directors
9
serving now
Independent
8 of 8
stated in the proxy; 1 not stated
Average tenure
6.2 years
from year joined
CEO also chairs the board
No
Andrew Y. Yan
Director Age On board Independent Committees Pay Source
Andrew Y. Yan
68 2025
1 year
Independent
Compensation Committee Corporate Governance and Nominating Committee · Chair Litigation Committee · Chair
Not stated
Weidong Yin
62 2025
1 year
Not stated None stated Paid as CEO
Simon Anderson
65 2004
22 years
Independent
Audit Committee · Chair
Not stated
Shan Fu
58 2018
8 years
Independent
Compensation Committee
Not stated
Shuge Jiao
60 2025
1 year
Independent None stated Not stated
Chiang Li
61 2025
1 year
Independent None stated Not stated
Yuk Lam Lo
76 2006
20 years
Independent
Audit Committee Compensation Committee · Chair Litigation Committee
Not stated
Yumin Qiu
53 2025
1 year
Independent
Corporate Governance and Nominating Committee
Not stated
Yu Wang
69 2025
1 year
Independent
Corporate Governance and Nominating Committee
Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No proxy statement on record

Related-party transactions come from the company’s proxy statement. SINOVAC BIOTECH LTD has not filed one with the SEC.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support